Tan et al. observed that patients with early proliferation of SARS-CoV-2-specific interferon gamma-secreting T-cells had milder disease and faster viral clearance.(26)Ehmsen et al. observed a worse cellular immune response in patients with onco-hematological diseases 36 days after the administration of two doses of MRNAV. Here, IFNG is linked to hematologic disorder.